What We're Reading: Page 203
Industry reads hand-picked by our editors
Apr 02, 2020
-
STAT
Big biotech venture funds raise billions despite coronavirus fears
-
The Washington Post
Anthony Fauci’s security is stepped up as doctor and face of U.S. coronavirus response receives threats
-
CNN
The 'game changer' that wasn't: Company falsely claimed FDA authorization for coronavirus blood test
Apr 01, 2020
-
MIT Technology Review
Why I am volunteering to get the coronavirus vaccine
-
POLITICO
White House pressures FDA on unproven Japanese drug
-
The Wall Street Journal
Coronavirus Survivors Keep Up the Fight, Donate Blood Plasma to Others
Mar 31, 2020
-
Slate
Didier Raoult: The Trumpian French doctor behind the chloroquine hype
-
STAT
A sickle cell doctor tracks dollars, disparities, and drug development
-
Los Angeles Times
Social distancing is slowing the coronavirus in Seattle. But it's not enough, study says
-
The New York Times
Covid-19 Has Closed Stores, but Snake Oil Is Still for Sale
Mar 30, 2020
Mar 27, 2020
-
The New York Times
The Unseen Survivors of Thalidomide Want to Be Heard
-
Axios
Top Trump administration health officials surprised by coronavirus drug's new status
-
The New Yorker
How Does the Coronavirus Behave Inside a Patient?
-
ProPublica
Republican Billionaire’s Group Pushes Unproven COVID-19 Treatment Trump Promoted
Mar 26, 2020
Mar 25, 2020
-
The Washington Post
The coronavirus isn't mutating quickly, suggesting a vaccine would offer lasting protection
-
Reuters
U.S. companies, labs rush to produce blood test for coronavirus immunity
-
STAT
India bans exports of drug touted by Trump as potential Covid-19 treatment
-
Regulatory Focus
Convalescent Plasma: FDA Facilitating Emergency Access
Previous
